The clinical trial environment was already evolving at a rapid pace before the presence of COVID-19, but now speed and efficiency are paramount. With a focus toward achieving faster time to market, reducing R&D costs, and increasing clinical trial success rates, various digital tools such as AI, machine learning, telemedicine are quickly becoming the next frontier in clinical studies.
Alongside the case study sharing of these digital strategies, multiple illustrative examples will be used to present the practical considerations and execution of designing and running various adaptive design strategies, including logistics and impact on clinical operations, data management, and randomization services with focus on implications for statisticians.
The Expert Speakers –
Dr. Chen Guang, Consultant and Clinical Diagnostics Technologist, Stronghold Diagnostic Lab – A*STAR, Singapore
Dr. Harish Dave, Co-founder and Chief Medical Officer, AUM Biosciences, Singapore
Dr. Tam C. Nguyen, Deputy Director of Research, St. Vincent’s Hospital Melbourne, Associate Professor, Melbourne Medical School, Adjunct Associate Professor, RMIT University, Australia
Dr. K. Arnold Chan, Director of Clinical Trial Center, National Taiwan University Hospital, Taiwan